Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elodie Vauléon

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Trends in Pharmacological Sciences|April 14, 2019
Rethinking Alkylating(-Like) Agents for Solid Tumor ManagementHélène Lajous, Bénédicte Lelièvre, Elodie Vauléon, et al.
Clinical Nuclear Medicine|April 2, 2019
FDG PET in Diffuse Spinal Carcinomatous MeningitisCécile Cuvilliers, Flora Ahrweiller, Elodie Vauléon, et al.
Bulletin Du Cancer|April 5, 2011
[MGMT analysis in gliomas]Véronique Quillien, Elodie Vauléon, Stephan Saikali, et al.
Medical Oncology (Northwood, London, England)|October 12, 2010
Impressive efficacy of sorafenib in a patient with an hepatocellular carcinoma and a portal vein thrombosis associated with a metastatic ENT cancerCatherine Leroux, Elodie Vauléon, Marc Pracht, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2021
Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head and neck squamous cell carcinomaEmeline Guiard, Florian Clatot, Caroline Even, et al.
Gastroenterologie Clinique Et Biologique|March 2, 2005
Tonsillar metastasis revealing signet-ring cell carcinoma of the rectumElodie Vauléon, Anne-Sophie De Lajarte-Thirouard, Eveline Boucher, et al.
Journal of Oncology|January 14, 2010
Management of esophageal carcinoma associated with cirrhosis: a retrospective case-control analysisFlorence Trivin, Eveline Boucher, Elodie Vauléon, et al.
Cancer|June 30, 2011
Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinomaJulien Edeline, Eveline Boucher, Yan Rolland, et al.
Cancer Chemotherapy and Pharmacology|September 29, 2009
Usefulness of chemotherapy beyond the second line for metastatic breast cancer: a therapeutic challengeElodie Vauléon, Habiba Mesbah, Brigitte Laguerre, et al.
BMC Medical Genomics|September 18, 2012
Immune genes are associated with human glioblastoma pathology and patient survivalElodie Vauléon, Avril Tony, Abderrahmane Hamlat, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Trends in Pharmacological Sciences|April 14, 2019
Rethinking Alkylating(-Like) Agents for Solid Tumor ManagementHélène Lajous, Bénédicte Lelièvre, Elodie Vauléon, et al.
Clinical Nuclear Medicine|April 2, 2019
FDG PET in Diffuse Spinal Carcinomatous MeningitisCécile Cuvilliers, Flora Ahrweiller, Elodie Vauléon, et al.
Bulletin Du Cancer|April 5, 2011
[MGMT analysis in gliomas]Véronique Quillien, Elodie Vauléon, Stephan Saikali, et al.
Medical Oncology (Northwood, London, England)|October 12, 2010
Impressive efficacy of sorafenib in a patient with an hepatocellular carcinoma and a portal vein thrombosis associated with a metastatic ENT cancerCatherine Leroux, Elodie Vauléon, Marc Pracht, et al.
European Journal of Cancer (Oxford, England : 1990)|November 7, 2021
Impact of previous nivolumab treatment on the response to taxanes in patients with recurrent/metastatic head and neck squamous cell carcinomaEmeline Guiard, Florian Clatot, Caroline Even, et al.
Gastroenterologie Clinique Et Biologique|March 2, 2005
Tonsillar metastasis revealing signet-ring cell carcinoma of the rectumElodie Vauléon, Anne-Sophie De Lajarte-Thirouard, Eveline Boucher, et al.
Journal of Oncology|January 14, 2010
Management of esophageal carcinoma associated with cirrhosis: a retrospective case-control analysisFlorence Trivin, Eveline Boucher, Elodie Vauléon, et al.
Cancer|June 30, 2011
Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinomaJulien Edeline, Eveline Boucher, Yan Rolland, et al.
Cancer Chemotherapy and Pharmacology|September 29, 2009
Usefulness of chemotherapy beyond the second line for metastatic breast cancer: a therapeutic challengeElodie Vauléon, Habiba Mesbah, Brigitte Laguerre, et al.
BMC Medical Genomics|September 18, 2012
Immune genes are associated with human glioblastoma pathology and patient survivalElodie Vauléon, Avril Tony, Abderrahmane Hamlat, et al.
Pageof 2